Eurofins Genomics Germany GmbH
Anzinger Strasse 7a
D-85560
Ebersberg bei München
Germany
Phone: +49 8092 82 89 21 7
Fax: +49 8092 82 89 20 1
pharmacogenetics-eu@eurofins.com
www.eurofins.com/genomic-pharma
Get Directions
Eurofins Genomics specialises in pharmacogenetics and pharmacogenomics. In these areas Eurofins Genomics offers a comprehensive services portfolio for the entire drug development process, from preclinical research to clinical phase III trials.
The drug development service portfolio for the modern biopharmaceutical industry includes an exclusive marker set for the general identification of responders/ non-responders in the scope of clinical studies and expert consultation by an academic partner in pharmacogenetics.
Together with other Eurofins companies like Medinet, Optimed, Lancaster Laboratories and AROS a complete service package for even worldwide multi-central registration studies is offered.
Services:
- DNA/ RNA-extraction, e.g. for biobanking
- GLP compliant genotyping and sequencing
- High-throughput genotyping
- SNP, mutation and biomarker analysis
- Analysis of candidate genes
- Expression analysis by Real Time PCR
- Microarrays, e. g. SNP analysis and gene expression
- Biological safety testing, e.g. residual DNA testing or analysis of production strains and cell banks
- Next Generation Sequencing (NGS), like adventitious virus testing, tumour profiling/ cancer sequencing, exome sequencing, whole genome sequencing, transcriptome analysis
- Bioinformatics
- Virus and microbiological diagnostics: Virus load determination, genotyping, sequencing and quantitative analyses of viruses and bacteria
- Oligo and Gene Synthesis
- Assay development and validation
- Scientific consultancy
- Comprehensive and well-founded consultancy prior to all projects/studies
- Professional project management during the complete project/study
- Dedicated project managers and study directors as competent and reliable contact persons
- Expert advice on the evaluation and interpretation of results
Accreditations:
The QM/QA-system of Eurofins Genomics is certified according to ISO 9001, including the requirements of ISO 13485 (medical devices requirements). Furthermore we are accredited according to ISO 17025 covering molecular testing methods like Sanger sequencing (e.g. for genotyping within clinical trials), quantitative Real-Time PCR, fragment length polymorphisms analysis and mass spectrometry-based DNA analysis. In addition ISO 17025 accreditation covers next generation sequencing with Illumina and Roche 454 technologies. Eurofins Genomics is also compliant to the principles of Good Laboratory Practice (GLP) and Good Clinical Practice (GCP). We are consistently audited by clients from the pharmaceutical industry according to these GxP regulations. We also regularly perform facility and process audits. We are participating in external proficiency testing (ring trials) on a regular basis.